Grimm, D.O., F.A.C.C. We also managed to find a correlation between the improvement on NYHA functional class and a reduction in the combined end-point of death, readmission for heart failure ...

However, the benefit of perindopril in decreasing heart failure hospitalizations ... outcomes in the treatment group: NYHA class improved from 3 to 2.4 (p = 0.005) and exercise time with the ...

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging data from a first-in ...

Progress with transcatheter tricuspid valve replacement (TTVR) candidate devices Topaz, LuX-Valve Plus, VDyne, and Trisol for ...

CM, offers strong efficacy and a favorable safety profile compared to competitors. See why I rate ALNY stock a Hold.

Breakthroughs in tricuspid and mitral valve repair signal progress in heart treatment. BEIJING, June 3, 2025 /PRNewswire/ -- ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Aficamten was associated with improved peak oxygen uptake and a tolerable safety profile vs. metoprolol, a beta-blocker, in ...

There were also improvements in other measures like the NYHA Functional Class (NYHA FC), Minnesota Living with Heart Failure Questionnaire ... it acquired AskBio for $4 billion, and has been ...

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

An early increase in serum TTR levels on Day 28 of dosing was associated with reduced all-cause mortality (ACM) in univariate analysis, an association which persisted in multivariate analysis ...